The gamma globulin for polio clinical trials: victims of marketing success

Stephen Mawdsley

Research output: Contribution to journalArticlepeer-review

89 Downloads (Pure)


Publicity played an integral role in the first 'gold standard' clinical trial of gamma globulin in the prevention of paralytic polio. Although the experiment, conducted on an open population, was a marketing success, its integrity was compromised by the response to publicity.
Original languageEnglish
Publication statusPublished - 24 Jul 2017


  • gamma globulin
  • polio
  • William Hammon
  • national foundation for infantile paralysis
  • Jonas Salk
  • clinical trial
  • epidemics
  • immunization

Cite this